Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬ £¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

°²Ë¹Ì©À´/Seagen¹«Ë¾Á¢ÒìADCÔÚÖйúÉ걨ÉÏÊÐØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ

2023-03-10
|
»á¼ûÁ¿£º

2022.03.11.png

Ò½ÏßÒ©ÎÅ

1¡¢3ÔÂ10ÈÕ£¬£¬£¬ £¬£¬£¬°²Ë¹Ì©À´£¨Astellas£©ºÍSeagen¹«Ë¾Ðû²¼£¬£¬£¬ £¬£¬£¬Öйú¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾ÖÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©ÒÑÊÜÀíenfortumab vedotinµÄÉúÎïÖÆÆ·ÔÊÐíÉêÇ루BLA£©£¬£¬£¬ £¬£¬£¬ÓÃÓÚÖÎÁƼÈÍù½ÓÊܹýPD-1/PD-L1ÒÖÖÆ¼ÁºÍº¬²¬»¯ÁÆÖÎÁƵľֲ¿ÍíÆÚ»ò×ªÒÆÐÔÄò·ÉÏÆ¤°©»¼Õß¡£¡£¡£¹ûÈ»×ÊÁÏÏÔʾ£¬£¬£¬ £¬£¬£¬enfortumab vedotin£¨Ó¢ÎÄÉÌÆ·ÃûΪPadcev£©ÊÇÒ»ÖÖ¡°first-in-class¡±µÄ¿¹ÌåżÁªÒ©ÎADC£©£¬£¬£¬ £¬£¬£¬ÓÉSeagen¹«Ë¾£¨Ô­ÃûΪSeattle Genetics£©ºÍ°²Ë¹Ì©À´ÁªºÏ¿ª·¢¡£¡£¡£
2¡¢3ÔÂ10ÈÕ£¬£¬£¬ £¬£¬£¬¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾Ö¹ÙÍøÏÔʾ£¬£¬£¬ £¬£¬£¬ÒæÆÕÉú¿ª·¢µÄ5.1ÀàÐÂÒ©×¢ÉäÓÃË«ôÇÝÁËáÇúÆÕÈðÁÖ»ñÅúÉÏÊС£¡£¡£2022Äê7ÔÂ21ÈÕ£¬£¬£¬ £¬£¬£¬¸Ã²úÆ·£¨ÊÜÀíºÅJXHS2200066£©Ôø±»ÄÉÈëÓÅÏÈÉóÆÀ£¬£¬£¬ £¬£¬£¬¶ÔÓ¦µÄ˳Ӧ֢Ϊ¾Ö²¿ÍíÆÚºÍ×ªÒÆÐÔǰÏßÏÙ°©¡¢×Ó¹¬ÄÚĤÒìλ֢¡¢ÖÐÊàÐÔÐÔÔçÊ죨8ËêǰµÄÅ®º¢ºÍ10ËêǰµÄÄк¢£©¡£¡£¡£
3¡¢3ÔÂ10ÈÕ£¬£¬£¬ £¬£¬£¬Ò©¼à¾Ö¹ÙÍøÏÔʾ£¬£¬£¬ £¬£¬£¬ÆëÂ³ÖÆÒ©ÓëÕý´óÌìÇçÅàßòÅÁÄáÆ¬¾ù»ñÅúÉÏÊУ¬£¬£¬ £¬£¬£¬Ë³Ó¦Ö¢ÎªÉöϸ°û°©¸¨ÖúÖÎÁÆ¡£¡£¡£ÕâÊǺ£ÄÚÉÏÊеÄǰÁ½¿îÅàßòÅÁÄá·ÂÖÆÒ©¡£¡£¡£ÅÁßòÅÁÄᣨpazopanib£©ÊÇÓɸðÀ¼ËØÊ·¿Ë¹«Ë¾Ñз¢µÄÒ»ÖÖ¿É×ÌÈÅÍç¹ÌÖ×Áö´æ»îºÍÉú³¤ËùÐèµÄÐÂѪ¹ÜÌìÉúµÄÐÂÐͿڷþѪ¹ÜÌìÉúÒÖÖÆ¼Á
4¡¢3ÔÂ9ÈÕ£¬£¬£¬ £¬£¬£¬ºÏÔ´ÉúÎïÐû²¼ºÕ»ùÂØÈü×¢ÉäÒº£¨Öƶ©£©µÄÐÂÒ©ÁÙ´²ÊÔÑéÉêÇëÒÑ»ñÃÀ¹úFDAÔÊÐí£¬£¬£¬ £¬£¬£¬ÓÃÓÚÖÎÁƳÉÈ˸´·¢»òÄÑÖÎÐÔBϸ°ûÐͼ±ÐÔÁܰÍϸ°û°×Ѫ²¡£¡£¡£¨r/r B-ALL£©¡£¡£¡£Æ¾Ö¤ºÏÔ´ÉúÎïÐÂΟ壬£¬£¬ £¬£¬£¬ºÕ»ùÂØÈü×¢ÉäÒºÊÇÒ»¿î°ÐÏòCD19µÄCAR-T²úÆ·£¬£¬£¬ £¬£¬£¬ÒÑÔÚÖйúµÝ½»ÐÂÒ©ÉÏÊÐÉêÇ루NDA£©£¬£¬£¬ £¬£¬£¬ÓÐÍûÄêÄÚ»ñµÃÅú×¼¡£¡£¡£

ͶÈÚÒ©ÊÂ

1¡¢3ÔÂ10ÈÕ£¬£¬£¬ £¬£¬£¬ÉϺ£ÔóµÂÂüÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾Ðû²¼Íê³ÉÒÚÔªAÂÖÈÚ×Ê£¬£¬£¬ £¬£¬£¬±¾ÂÖÈÚ×ÊÕÙļ×ʽðÖ÷ÒªÓÃÓÚ¼ÓËÙ·¼ÏãÌþÊÜÌ壨AhR£©°Ðµã¶à¸öÏà¹Ø×ÔÉíÃâÒßÑ×Ö¢ÐÔ¼²²¡ÖÎÁÆÒ©ÎïµÄÑз¢ºÍÁÙ´²Ñо¿¡£¡£¡£
2¡¢¿ËÈÕ£¬£¬£¬ £¬£¬£¬OPKO Health¹«Ë¾Ðû²¼£¬£¬£¬ £¬£¬£¬ÆäÆìϹ«Ë¾ModeX TherapeuticsÓëĬɳ¶«£¨MSD£©¸æ¿¢Ò»ÏîÈ«Çò¶À¼ÒÔÊÐíºÍÏàÖúЭÒ飬£¬£¬ £¬£¬£¬ÒÔ¿ª·¢ModeX¹«Ë¾°ÐÏò°®ÆÃ˹̹-°Í¶û²¡¶¾£¨EBV£©µÄÁÙ´²Ç°ÄÉÃ׿ÅÁ£ºòÑ¡ÒßÃçMDX-2201¡£¡£¡£

¿Æ¼¼Ò©ÑÐ

1¡¢ÐÄѪ¹Ü¼²²¡£¡£¡£¨CVD£©ÊÇÈ«ÇòÈËȺéæÃüºÍÉ˲е÷½âÉúÃüÄ꣨DALYs£¬£¬£¬ £¬£¬£¬disability adjusted life years£©ËðʧµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ£¬£¬£¬ £¬£¬£¬ÖîÈçÐÄÁ¦Ë¥½ßºÍÐÄ·¿²ü¶¶µÈÐÄѪ¹Ü¼²²¡ÍùÍùÓë¶ÔÐÄÔ༡ÈâµÄÎïÀíÐÔÓ°ÏìÓйØ¡£¡£¡£¿ËÈÕ£¬£¬£¬ £¬£¬£¬Ò»Æª½ÒÏþÔÚ¹ú¼ÊÔÓÖ¾GenomicsÉϵÄÑо¿±¨¸æÖУ¬£¬£¬ £¬£¬£¬À´×ÔÃÀ¹úÂÞ¸ñ˹´óѧµÈ»ú¹¹µÄ¿ÆÑ§¼ÒÃÇͨ¹ýÑо¿Ê¹ÓÃÈ˹¤ÖÇÄÜÀ´ÆÊÎöDNAÖеĻùÒò£¬£¬£¬ £¬£¬£¬´Ó¶ø¾ÍÄÜÀÖ³ÉÕ¹ÍûÈËȺ»¼ÐÄѪ¹Ü¼²²¡£¡£¡£¨ºÃ±ÈÐÄÁ¦Ë¥½ßºÍÐÄ·¿²ü¶¶µÈ£©µÄΣº¦[1]¡£¡£¡£

Vignesh Venkat, Habiba Abdelhalim, William DeGroat£¬£¬£¬ £¬£¬£¬et al. Investigating genes associated with heart failure, atrial fibrillation, and other cardiovascular diseases, and predicting disease using machine learning techniques for translational research and precision medicine, Genomics (2023). DOI:10.1016/j.ygeno.2023.110584

¹Ø×¢¡°ÃÀ¸ß÷Medicilon¡±¹«Öںţ¬£¬£¬£¬£¬£¬¶©ÔÄÀ¸Ä¿»ñÈ¡ÌìÌìÒ½Ò©×ÊѶ-1.png

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿